Perci Health has raised a further £3m to scale an AI-powered virtual cancer clinic.
This doubles its original funding target and means it has now raised a total of £7.7m in funding for its ‘human first, tech-enabled’ treatment model.
The funds will also enable Perci Health to expand its partnerships with both employers and insurers, ensuring that more people have access to its cancer care services.
Last year it supported over 4,000 members, with a total of 2.5m insurance lives covered, with the company saying it can demonstrate a four times ROI for its insurance partners
Perci Health was founded by two female healthcare innovators with the aim of redefining how cancer is managed – from treatment through to recovery. The company combines the latest technology with care from a multi-specialist team including nurses, dieticians, physiotherapists andpsychologists.
This new funding includes investment from Macmillan Cancer Support as well venture capital from Octopus Ventures, Guinness Venture and Conduit Funds.
This investment comes at a pivotal moment, with the UK government increasingly prioritising vocational rehabilitation and reducing long-term sickness absence with the release of Labour’s “Keep Britain Working Review”.
Perci Health says supports these goals by enabling earlier intervention, personalised recovery plans, and return-to-work programmes that address both physical and psychological barriers, tailored to the complex needs of people with cancer.
Perci Health co-founder and CEO Kelly McCabe says: “This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer.”
This approach aligns with Macmillan’s long-standing focus on work and cancer, raising awareness about the importance of employment in enhancing wellbeing and quality of life.
Macmillan estimates that there are currently almost 3.5m people living with cancer in the UK and this number will continue to rise, creating an urgent need for new, effective ways to support patients. As more people are diagnosed with cancer at younger ages and survival rates improve, there is a growing population of working-age people who need ongoing support to stay in or return to work after treatment.
In the UK, cancer outcomes lag up to 25 years behind European peers, with 41 per cent of staged diagnoses being at a late stage in England, and around a third of eligible people missing critical screening appointments for breast, bowel and cervical cancer.
Perci Health says that improving these outcomes will require collaboration across the government, NHS, private insurers, charities, and employers.
It ads that its model aims to address these gaps by offering comprehensive care that spans prevention, early detection, treatment navigation, symptom management, and survivorship care.
Perci Health says its ultimate goal is to radically improve global cancer outcomes by delivering supportive cancer care through a digital, AI-native care model.
Octopus Venture Chantal Cox says: “We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model.
“This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”
McCabe adds: “With more people living with cancer, there’s an urgent need for healthcare solutions that cater to long-term survivorship.
“By working with insurers, employers, and healthcare providers, we aim to reshape cancer care to ensure better outcomes for patients and cost savings for the system.”
Perci Health remains as one of the few UK scale-ups with an all-female founding team. All of its directors, 80 per cent of its leadership team and 60 per cent of its executive board are women and it has raised twice the average deal size for UK female-led startups in each of its funding rounds.
